Safety and efficacy of a simplified fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) for the treatment of advanced HIV-infected patients: a 24-week study (Q45134803)
Jump to navigation
Jump to search
scientific article published in July 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of a simplified fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) for the treatment of advanced HIV-infected patients: a 24-week study |
scientific article published in July 2004 |
Statements
1 reference
Safety and efficacy of a simplified fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) for the treatment of advanced HIV-infected patients: a 24-week study (English)
1 reference
Thanomsak Anekthananon
1 reference
Winai Ratanasuwan
1 reference
Wichai Techasathit
1 reference
Areeaue Sonjai
1 reference
Surapol Suwanagool
1 reference
1 July 2004
1 reference
87
1 reference
7
1 reference
760-767
1 reference
Identifiers
1 reference